OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Social Drivers of Cancer Risk and Outcomes Among African American Men	32
Toxicities From Antibody-Drug Conjugates	31
Oncology Physician Workforce Diversity	25
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	24
Building a Bridge to Equity in Health and Health Care in Cancer Care	22
PET Imaging of Metabolism, Perfusion, and Hypoxia	22
Health Care Policy and Disparities in Health	20
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	19
Nonoperative Management for Rectal Cancer	18
Melanoma—Modern Treatment for Metastatic Melanoma	18
Stereotactic Body Radiation Therapy	18
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	15
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	15
Primary Prevention of Cancer	15
Antibody Drug Conjugates in Multiple Myeloma	14
Diversity in Cancer Care	14
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	13
Germline Predisposition to Myelodysplastic Syndromes	13
Metastatic Melanoma Treatment in Special Populations	13
Prostate Cancer, Race, and Health Disparity	13
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	12
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	12
Rectal Cancer—The Only Constant Is Change	12
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	11
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	11

Advances in Stereotactic Body Radiation Therapy for Lung Cancer	11
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	11
Updates in the Management of Uveal Melanoma	10
Supportive Care for Patients With Myelodysplastic Syndromes	10
Telehealth and Technology	9
New Metabolomic Insights Into Cancer	9
Introduction	9
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	9
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	8
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	8
Impact of Precision Medicine in Oncology	8
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	7
Role of the Microbiome in Immunotherapy of Melanoma	7
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	7
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	7
How Far We’ve Come	7
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	7
Discovery of Natural Products for Cancer Prevention	7
Gene Expression Profiles in Cancers and Their Therapeutic Implications	6
Survival of the Fittest	6
What to Eat for Cancer Prevention	6
Repurposing Drugs for Cancer Prevention	6
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	6
Telemedicine and Cancer Care	6
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	6
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	6
Molecular Imaging of Steroid Receptors in Breast Cancer	6
The Gut Microbiome and Pancreatic Cancer Development and Treatment	5
STING Agonists in Head and Neck Squamous Cell Carcinoma	5
Updates in Classification of Myelodysplastic Syndrome	5
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases	5
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation	5
Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer	5
Local Excision for Early-Stage Rectal Adenocarcinomas	5
Chimeric Antigen Receptor T-Cell Therapy	5
Impact of Precision Medicine in Oncology	5
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation	5
Antibody-Drug Conjugates in Myeloid Leukemias	5
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	5
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	4
Digital Health for Oncological Care	4
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	4
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	4
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	4
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	4
Management of Low-Grade Gliomas	4
Radiopharmaceuticals for Cancer Diagnosis and Therapy	4
Diversity and Disparities in Lung Cancer Outcomes Among Minorities	3
The Promise of Cancer Health Justice	3
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	3

Targets for Cancer Prevention: Evolving Methodologies in Basic and Epidemiological Sciences Identify Interrelated Pathways and the Need for Holistic Approaches	3
Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers	3
The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer	3
Fecal Microbiota Transplantation as a Cancer Therapeutic	3
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools	3
T3N0 Rectal Cancer	3
Shifting the Landscape of Spine and Non-Spine Bone Metastases	3
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	3